BIOMAT Database Logo BIOMAT Database Logo

Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. 2022

Ksenia S Maslyonkina, and Alexandra K Konyukova, and Darya Y Alexeeva, and Mikhail Y Sinelnikov, and Liudmila M Mikhaleva
Research Institute of Human Morphology, Moscow, Russian Federation.

Barrett's esophagus is a widespread chronically progressing disease of heterogeneous nature. A life threatening complication of this condition is neoplastic transformation, which is often overlooked due to lack of standardized approaches in diagnosis, preventative measures and treatment. In this essay, we aim to stratify existing data to show specific associations between neoplastic transformation and the underlying processes which predate cancerous transition. We discuss pathomorphological, genetic, epigenetic, molecular and immunohistochemical methods related to neoplasia detection on the basis of Barrett's esophagus. Our review sheds light on pathways of such neoplastic progression in the distal esophagus, providing valuable insight into progression assessment, preventative targets and treatment modalities. Our results suggest that molecular, genetic and epigenetic alterations in the esophagus arise earlier than cancerous transformation, meaning the discussed targets can help form preventative strategies in at-risk patient groups.

UI MeSH Term Description Entries
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D001471 Barrett Esophagus A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus. Barrett Syndrome,Esophagus, Barrett,Barrett Epithelium,Barrett Metaplasia,Barrett's Esophagus,Barrett's Syndrome,Barrett Metaplasias,Barretts Esophagus,Barretts Syndrome,Epithelium, Barrett,Esophagus, Barrett's,Metaplasia, Barrett,Metaplasias, Barrett
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D044127 Epigenesis, Genetic A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression. Epigenetic Processes,Epigenetic Process,Epigenetics Processes,Genetic Epigenesis,Process, Epigenetic,Processes, Epigenetic,Processes, Epigenetics
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Ksenia S Maslyonkina, and Alexandra K Konyukova, and Darya Y Alexeeva, and Mikhail Y Sinelnikov, and Liudmila M Mikhaleva
Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus.
May 1995, Cancer research,
Ksenia S Maslyonkina, and Alexandra K Konyukova, and Darya Y Alexeeva, and Mikhail Y Sinelnikov, and Liudmila M Mikhaleva
Barrett's esophagus: model of neoplastic progression.
September 2003, World journal of surgery,
Ksenia S Maslyonkina, and Alexandra K Konyukova, and Darya Y Alexeeva, and Mikhail Y Sinelnikov, and Liudmila M Mikhaleva
Barrett's esophagus: the biology of neoplastic progression.
January 1994, Gastroenterologie clinique et biologique,
Ksenia S Maslyonkina, and Alexandra K Konyukova, and Darya Y Alexeeva, and Mikhail Y Sinelnikov, and Liudmila M Mikhaleva
Predicting Neoplastic Progression in Barrett's Esophagus.
June 2010, Annals of gastroenterology & hepatology,
Ksenia S Maslyonkina, and Alexandra K Konyukova, and Darya Y Alexeeva, and Mikhail Y Sinelnikov, and Liudmila M Mikhaleva
p53 and neoplastic progression in Barrett's esophagus.
May 2001, The American journal of gastroenterology,
Ksenia S Maslyonkina, and Alexandra K Konyukova, and Darya Y Alexeeva, and Mikhail Y Sinelnikov, and Liudmila M Mikhaleva
Barrett's esophagus: a model of human neoplastic progression.
January 1994, Cold Spring Harbor symposia on quantitative biology,
Ksenia S Maslyonkina, and Alexandra K Konyukova, and Darya Y Alexeeva, and Mikhail Y Sinelnikov, and Liudmila M Mikhaleva
Natural selection in neoplastic progression of Barrett's esophagus.
December 2005, Seminars in cancer biology,
Ksenia S Maslyonkina, and Alexandra K Konyukova, and Darya Y Alexeeva, and Mikhail Y Sinelnikov, and Liudmila M Mikhaleva
Risk factors for neoplastic progression in Barrett's esophagus.
August 2011, World journal of gastroenterology,
Ksenia S Maslyonkina, and Alexandra K Konyukova, and Darya Y Alexeeva, and Mikhail Y Sinelnikov, and Liudmila M Mikhaleva
Early events during neoplastic progression in Barrett's esophagus.
January 2010, Cancer biomarkers : section A of Disease markers,
Ksenia S Maslyonkina, and Alexandra K Konyukova, and Darya Y Alexeeva, and Mikhail Y Sinelnikov, and Liudmila M Mikhaleva
Molecular phenotype of spontaneously arising 4N (G2-tetraploid) intermediates of neoplastic progression in Barrett's esophagus.
July 2003, Cancer research,
Copied contents to your clipboard!